Cargando…
Cytoreductive prostatectomy: Evidence in support of a new surgical paradigm (Review)
Prostate cancer (PCa) remains the second ranked cause of cancer deaths in the United States. The current standard of care for metastatic prostate cancer (mPCa) includes systemic therapies with no option for surgery. In contrast, in other malignancies such as breast and kidney cancer, cytoreduction p...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215584/ https://www.ncbi.nlm.nih.gov/pubmed/25340386 http://dx.doi.org/10.3892/ijo.2014.2656 |